Simon is a highly experienced biotechnology executive and entrepreneur, focusing on the discovery, development and commercialisation of novel medicines. He completed his PhD in the field of immunology at the University of Melbourne in 1992 and has worked at Genentech, Novartis, Chiron and CSL Limited, where he was Senior Vice President of Global Plasma R&D and General Manager of Manufacturing Operations in Australia and Germany.
Simon is the founder and Chief Executive Officer of Immunosis Pty Ltd, a biotech start-up company focused on improved diagnostic outcomes for patients with immune deficiencies. Simon’s breadth of skills covers R&D drug development, corporate due diligence, acquisitions and integration, strategic planning, portfolio management, financial management, intellectual property management, risk management, business development, contract management and organizational design.
Simon is a graduate of the Australian Institute of Company Directors and has Non-Executive Director experience in ASX listed companies including Clover Corporation (2020 – present) and Acrux Pty Ltd (2016-2019). He is also a Venture Partner at BioScience Managers, a health care investment firm.
Simon has worked closely with the Imunexus team to review the core science, patent portfolio, provide advice on the drug development process and identification of lead product candidates.